HPS Pharmacies wish to advise that Alphapharm, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall for Tenofovir Disoproxil Emtricitabine Mylan 300/200 tablets as follows:
Tenofovir Disoproxil Emtricitabine Mylan Tablets
Tenofovir disoproxil maleate + Emtricitabine 300mg/200mg
All batches of the above product have been recalled due to the potential for broken or split tablets. Administration of an affected tablet could result in the delivery of an ineffective dose.
Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Alphapharm on 1800 274 276, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates